Clinwis Practice CFO & Business Analyst

The package a buyer’s analyst builds — already built.

Finance terms are used here so a buyer, lender, or broker sees what they expect. Each term is followed by the plain-English name your CFO uses on the rest of the app.

Demo shows illustrative models. In your practice these run on your live books.

EBITDA bridge / from collections to true profit

Every step a buyer’s analyst walks — from the top-line the practice collected, through operating costs, to the normalized earnings they underwrite.

$1,360,000
Collections
money the practice actually got paid
−$1,258,810
Operating costs
cost to run the practice
$101,190
Booked profit
what the tax return shows
+$91,000
Owner salary above fair replacement pay
add-back
+$9,360
Vehicle lease (personal use)
add-back
+$27,600
Family member on payroll
add-back
+$17,400
Owner health & life insurance
add-back
+$18,000
One-time legal settlement
add-back
+$10,200
Equipment loan interest
add-back
$274,750
Normalized EBITDA
true profit a buyer will underwrite
Anchor Cost out Add-back in Subtotal
Normalized EBITDA
$274,750
a.k.a. true profit · 20.2% EBITDA margin
Collections: $1,360,000
Operating costs: $1,258,810
Booked profit: $101,190
Owner add-backs: +$173,560

Revenue build / where the top line actually comes from

The driver model a PE analyst checks first: provider-days × production per day × collection rate = collections. Change any assumption to see the 5-year build react.

YearProvider-daysProduction / dayGross productionCollection rateCollections
TTM205$6,756$1,384,98098.2%$1,360,050
Y1209$6,925$1,447,99798.2%$1,421,933
Y2213$7,098$1,513,88098.2%$1,486,631
Y3218$7,275$1,582,76298.2%$1,554,272
Y4222$7,457$1,654,77898.2%$1,624,992
Y5226$7,644$1,730,07098.2%$1,698,929
Y5 collections $1,698,929 · 5-year uplift +$338,878Collections = provider-days × production/day × collection rate
Market context
For you

Comps and multiples / what practices like yours sell for

Illustrative industry transactions by size, margin, and location. The closest row to your collections is highlighted; multiples are what buyers actually pay in the market, not a model output.

Practice typeRegionCollectionsTrue-profit marginSale price% of collectionsMultiple
Solo GPSuburban$900K16.0%$558K62%3.9×
Solo GPRural$1.00M18.0%$640K64%3.6×
Solo GPSuburban$1.15M19.0%$759K66%3.5×
Solo GPUrban$1.25M20.0%$850K68%3.4×
Solo GPclosest to youSuburban$1.35M20.0%$945K70%3.5×
Solo GPUrban$1.50M21.0%$1.08M72%3.4×
Solo GPUrban$1.60M22.0%$1.25M78%3.5×
Two-doctorSuburban$1.75M23.0%$1.40M80%3.5×
Valuation cross-check
Context only

DCF cross-check — modeled, directional

Practices transact on multiples; this is a second opinion, not a price. Five years of free cash flow off the revenue build above, plus a terminal value at year five, all discounted back to today. Move the two knobs a buyer argues over — discount rate and exit multiple — and watch enterprise value react.

YearCollectionsEBITDA / true profitFree cash flow after taxDiscount factorPresent value
Y1$1,421,933$287,230$215,4230.806$173,728
Y2$1,486,631$300,299$225,2250.650$146,478
Y3$1,554,272$313,963$235,4720.524$123,502
Y4$1,624,992$328,248$246,1860.423$104,130
Y5$1,698,929$343,184$257,3880.341$87,797
Terminal value at Y5 · 4.5× EBITDA = $1,544,326 nominal$526,782
Enterprise value
$1,162,417
a.k.a. what a buyer would pay for the whole business today
PV of 5-year cash flows: $635,635
PV of terminal value: $526,782
Tax rate assumed: 25%
EBITDA margin held at: 20.2%

PE Quick Look / what a private-equity buyer would model in ten minutes

Enter at 4.5× EBITDA, fund half the check with debt at 9%, exit in year five at the same multiple. The equity check, the IRR, and the money-on-money are what a fund partner asks about first.

Equity check
$618,143
cash the fund writes at close
IRR
35.4%
annualized return on the equity check
MOIC
3.07×
multiple on invested capital
Entry · today
TTM EBITDA × 4.5×
$1,236,286
Debt (50% at 9%)
− $618,143
Equity check
$618,143
Annual interest (after tax)
$41,725
Exit · year 5
Y5 EBITDA × 4.5×
$1,544,326
Debt repaid
− $618,143
Equity proceeds at exit
$926,183
Dividends over hold
$971,070
YearEBITDAFCF after tax− Interest a-tDividend to equity
Y1$287,230$215,423$41,725$173,698
Y2$300,299$225,225$41,725$183,500
Y3$313,963$235,472$41,725$193,748
Y4$328,248$246,186$41,725$204,462
Y5$343,184$257,388$41,725$215,663
Y5 exit equity proceeds+ $926,183

Clean deal. The IRR is real; the negotiation is the owner-dependence discount — 71% of production runs through Dr. A, and a buyer will price that risk in.

3-year monthly P&L / the sheet a lender or buyer’s analyst will paste into their model

36 months of collections, operating costs by category, and booked EBITDA — driven off the revenue build above with realistic seasonality. Add-backs are itemized in the EBITDA bridge; this table is the pre-normalization view a buyer opens first.

Dental Practice A · monthlyFigures in USD, rounded
MonthCollectionsStaff wagesDental suppliesLab feesRent & occupancyMarketingOffice & adminOther operatingTotal op exEBITDA
Jan 26$116,124$30,076$7,548$9,290$7,548$2,787$4,064$4,645$65,959$50,166
Feb 26$118,494$30,690$7,702$9,480$7,702$2,844$4,147$4,740$67,305$51,190
Mar 26$124,419$32,225$8,087$9,954$8,087$2,986$4,355$4,977$70,670$53,749
Apr 26$120,864$31,304$7,856$9,669$7,856$2,901$4,230$4,835$68,651$52,213
May 26$122,049$31,611$7,933$9,764$7,933$2,929$4,272$4,882$69,324$52,725
Jun 26$120,864$31,304$7,856$9,669$7,856$2,901$4,230$4,835$68,651$52,213
Jul 26$111,385$28,849$7,240$8,911$7,240$2,673$3,898$4,455$63,267$48,118
Aug 26$109,015$28,235$7,086$8,721$7,086$2,616$3,816$4,361$61,920$47,094
Sep 26$119,679$30,997$7,779$9,574$7,779$2,872$4,189$4,787$67,978$51,701
Oct 26$124,419$32,225$8,087$9,954$8,087$2,986$4,355$4,977$70,670$53,749
Nov 26$123,234$31,918$8,010$9,859$8,010$2,958$4,313$4,929$69,997$53,237
Dec 26$111,385$28,849$7,240$8,911$7,240$2,673$3,898$4,455$63,267$48,118
2026 total$1,421,933$368,281$92,426$113,755$92,426$34,126$49,768$56,877$807,658$614,275
Jan 27$121,408$31,445$7,892$9,713$7,892$2,914$4,249$4,856$68,960$52,448
Feb 27$123,886$32,086$8,053$9,911$8,053$2,973$4,336$4,955$70,367$53,519
Mar 27$130,080$33,691$8,455$10,406$8,455$3,122$4,553$5,203$73,886$56,195
Apr 27$126,364$32,728$8,214$10,109$8,214$3,033$4,423$5,055$71,775$54,589
May 27$127,602$33,049$8,294$10,208$8,294$3,062$4,466$5,104$72,478$55,124
Jun 27$126,364$32,728$8,214$10,109$8,214$3,033$4,423$5,055$71,775$54,589
Jul 27$116,453$30,161$7,569$9,316$7,569$2,795$4,076$4,658$66,145$50,308
Aug 27$113,975$29,520$7,408$9,118$7,408$2,735$3,989$4,559$64,738$49,237
Sep 27$125,125$32,407$8,133$10,010$8,133$3,003$4,379$5,005$71,071$54,054
Oct 27$130,080$33,691$8,455$10,406$8,455$3,122$4,553$5,203$73,886$56,195
Nov 27$128,841$33,370$8,375$10,307$8,375$3,092$4,509$5,154$73,182$55,659
Dec 27$116,453$30,161$7,569$9,316$7,569$2,795$4,076$4,658$66,145$50,308
2027 total$1,486,631$385,037$96,631$118,930$96,631$35,679$52,032$59,465$844,406$642,224
Jan 28$126,932$32,875$8,251$10,155$8,251$3,046$4,443$5,077$72,098$54,835
Feb 28$129,523$33,546$8,419$10,362$8,419$3,109$4,533$5,181$73,569$55,954
Mar 28$135,999$35,224$8,840$10,880$8,840$3,264$4,760$5,440$77,247$58,751
Apr 28$132,113$34,217$8,587$10,569$8,587$3,171$4,624$5,285$75,040$57,073
May 28$133,408$34,553$8,672$10,673$8,672$3,202$4,669$5,336$75,776$57,632
Jun 28$132,113$34,217$8,587$10,569$8,587$3,171$4,624$5,285$75,040$57,073
Jul 28$121,751$31,534$7,914$9,740$7,914$2,922$4,261$4,870$69,155$52,597
Aug 28$119,161$30,863$7,745$9,533$7,745$2,860$4,171$4,766$67,683$51,477
Sep 28$130,818$33,882$8,503$10,465$8,503$3,140$4,579$5,233$74,305$56,513
Oct 28$135,999$35,224$8,840$10,880$8,840$3,264$4,760$5,440$77,247$58,751
Nov 28$134,704$34,888$8,756$10,776$8,756$3,233$4,715$5,388$76,512$58,192
Dec 28$121,751$31,534$7,914$9,740$7,914$2,922$4,261$4,870$69,155$52,597
2028 total$1,554,272$402,557$101,028$124,342$101,028$37,303$54,400$62,171$882,827$671,446
EBITDA here is booked — before the owner add-backs shown in the bridge above.Prepared by Clinwis Practice CFO & Analyst · demo data